Little consistency in price changes of top billed drugs under ASP

Article Overview

This article reviews Medicare Part B drug payment trends under the ASP-based methodology and looks at how prices shifted for commonly billed drugs across multiple years. It is relevant for coders, billing staff, and reimbursement professionals who track Part B drug payment changes, utilization trends, and the impact of CMS pricing methodology on drug billing. The piece provides a broad overview of the market-based pricing approach, compares historical payment movement for top-billed drugs, and places those changes in the context of Medicare billing data.